Background and Aims: Dose intensification of vedolizumab (VDZ) for moderate-to
CITATION STYLE
Outtier, A., Wauters, L., Rahier, J., Bossuyt, P., Colard, A., … Vermeire, S. (2021). Effect of vedolizumab dose intensification on serum drug concentrations and regain of response in inflammatory bowel disease patients with secondary loss of response. GastroHep, 3(2), 63–71. https://doi.org/10.1002/ygh2.444
Mendeley helps you to discover research relevant for your work.